COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 2846: Articles 28451-28460  | Next

FACT- Frankfurt adjusted COVID-19 testing- a novel method enables high-throughput SARS-CoV-2 screening without loss of sensitivity
Schmidt, M., Hoehl, S., Berger, A., Zeichhardt, H., Hourfar, K., Ciesek, S., Seifried, E.
10.1101/2020.04.28.20074187 — Posted: 2020-05-01
Severe Acute Respiratory Syndrome Coronavirus 2 Serology in Asymptomatic Healthcare Professionals: Preliminary Experience of a Tertiary Italian Academic Center.
Tosato, F., Pelloso, M., Gallo, N., Giraudo, C., Llanaj, G., Cosma, C., Pozzato, C., Padoan, A., Donato, D., Plebani, M.
10.1101/2020.04.27.20073858 — Posted: 2020-05-01
COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients
Haerter, G., Spinner, C. D., Roider, J., Bickel, M., Krznaric, I., Grunwald, S., Schabaz, F., Gillor, D., Postel, N., Mueller, M. C., Mueller, M., Roemer, K., Schewe, K., Hoffmann, C.
10.1101/2020.04.28.20073767 — Posted: 2020-05-01 Discussion: Onsite
Performance & Quality Evaluation of Marketed COVID-19 RNA Detection Kits
Kapitula, D. S., Jiang, Z., Jiang, J., Zhu, J., Chen, X., Lin, C. Q.
10.1101/2020.04.25.20080002 — Posted: 2020-05-01
Correlation analysis of risk factors and GSI score of a medical team assisting Wuhan city during the epidemic of COVID-19 in China -A cohort study
Cheng, W., Zhaohui, L., Jingquan, W., Xiaolei, J., Yunyun, F., Yanlin, W., Jinlong, Z.
10.1101/2020.04.27.20070466 — Posted: 2020-05-01
Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: a proof-of-concept for quantitative environmental surveillance
Bar Or, I., Yaniv, K., Shagan, M., Ozer, E., Erster, O., Mendelson, E., Mannasse, B., Shirazi, R., Kramarsky-Winter, E., Nir, O., Abu-Ali, H., Ronen, Z., Rinott, E., Lewis, Y. E., Friedler, E. F., Paitan, Y., Bitkover, E., Berchenko, Y., Kushmaro, A.
10.1101/2020.04.26.20073569 — Posted: 2020-05-01 Discussion: Onsite
Methods of An Open-Label Proof-Of-Concept Trial of Intravenous Valproic Acid for Severe COVID-19
Chiquete, E., Toapanta-Yanchapaxi, L., Cantu-Brito, C.
10.1101/2020.04.26.20079988 — Posted: 2020-05-01
Fast and easy disinfection of coronavirus-contaminated face masks using ozone gas produced by a dielectric barrier discharge plasma generator
Lee, J., Bong, C., Bae, P. K., Abafog, A. T., Baek, S. H., Shin, Y.-B., Park, M. S., Park, S.
10.1101/2020.04.26.20080317 — Posted: 2020-05-01
Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht
Tas, J., van Gassel, R. J., heines, S. J., Mulder, M. M., heijnen, N. F., Acampo - de Jong, M. J., Bels, J. L., Bennis, F. C., Koelmann, M., Groven, R. V., Donkers, M. A., van Rosmalen, F., Hermans, B. J., Meex, S. J., Mingels, A. M., Bekers, O., Savelkoul, P. H., Oude Lashof, A. M., Wildberger, J. E., Tijssen, F. H., Buhre, W. F., Sels, J. E., Ghossein-Doha, C., Driessen, R. G., Kubben, P. L., Janssen, M. L., Nicolaes, G. A., Strauch, U., Geyik, Z., Delnoij, T. S., Walraven, K. H., Stehouwer, C. D., Verbunt, J. A., van Mook, W. N., van Santen, S., Schnabel, R. M., Aries, M. J., van de Poll, M. C., Bergmans, D. C., van der Horst, I. C., van Kuijk, S. M., van Bussel, B. C., Maastricht Intensive Care COVID Study Group
10.1101/2020.04.27.20080309 — Posted: 2020-05-01
Using the COVID-19 to influenza ratio to estimate the numbers of symptomatic COVID-19 cases in Wuhan prior to the lockdown
Du, Z., Cowling, B. J., Meyers, L. A.
10.1101/2020.04.26.20075937 — Posted: 2020-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).